Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G - AN2 Therapeutics, Inc. | StockGist | StockGist

Companies
ANTX
SCHEDULE 13G

Home Top Movers Companies Concepts

Home Filings ANTXSCHEDULE 13G

SCHEDULE 13G

Beneficial Ownership

AN2 Therapeutics, Inc.

Filed Mar 13, 2026

Accepted Mar 13, 2026, 5:02 PM ET

CIK 0001880438

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Shares Owned

35,647,635

Reporting Person

AN2 Therapeutics, Inc.

Person Type

OO

CUSIP: 037326105

Amendment History

2 filings

SCHEDULE 13G
Original
Viewing
Mar 13, 20260001104659-26-027730
SCHEDULE 13G/A
Amendment 1
Latest
Feb 13, 20260001193125-26-051535

Key Facts

Shares Owned

35,647,635

Recent Filings

AN2 Therapeutics, Inc.2 weeks ago

AN2 Therapeutics, Inc.3 weeks ago

AN2 Therapeutics, Inc.1 months ago

AN2 Therapeutics, Inc.1 months ago

AN2 Therapeutics, Inc.2 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice